News

Elsiglutide, a novel GLP-2 peptide agonist, is discovered by Zealand Pharma and licensed to Helsinn Healthcare, and is indicated in the treatment of diarrhea induced by chemotherapy in

Prevnar 13 (Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM197 Protein]) has been recommended as a single dose for use in adults who are 50 years old or more. According

Xarelto is an oral anticoagulant that reduces the risk of (thrombotic) cardiovascular events in patients with Acute Coronary Syndrome (ACS). The drug candidate is also being assessed for

According to the company, MMJMenu provides business management software for dispensaries and growers, enabling them to track their medical cannabis from seed to sale. WeedMaps chief web officer

Remodulin is approved for the continuous subcutaneous infusion treatment of idiopathic or heritable PAH to improve exercise tolerance and symptoms of the disease. For intravenous Remodulin, United Therapeutics

OWH’s effectiveness study, which enrolled 120 patients, is gathering information on how safe and efficacious PMIM mono-therapy for VL is at a regional level. The study will also

With the termination of the agreement, Abbott will have to provide certain forms of transition assistance to Emergent for a certain period of time and Emergent will retain

The findings were the result of research partnership between Alnylam and Medtronic and supported by CHDI. The results demonstrated that a small interfering RNA (siRNA) targeting huntingtin gene,

Following the amendment of the deal, UCB gains the flexibility to select a partner to sublicense its rights for certain territories. In addition, in return for the right